Synergistic antileukemic therapies in NOTCH1-induced T-ALL.
Proceedings of the National Academy of Sciences of the United States of America.
Times cited: 11
Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias.
Times cited: 14